Skip to content
OpenCapital
Get started

GoodRx Holdings, Inc. GDRX Q4 2025 Annual earnings

Reported February 25, 2026 · After market close

Revenue$194.8MBeat by $1.5M
EPS$0.09In line
Revenue estimate$193.3M
EPS estimate$0.09

Next report

Aug 5, 2026 (In 1 week)
Revenue estimate$193.2M
EPS estimate$0.08

Financials

Q4 2025

Income statement

See full
Revenue$194.8M-1.9%
Gross profit$177.3M-4.9%
Operating income$22.7M+24.8%
Net income$5.4M-19.5%
EPS (diluted)$0.020.0%

Balance sheet

See full
Cash & equivalents$261.8M-41.6%
Total debt$542.8M-0.1%
Total equity$616.3M-15.0%
Total assets$1.4B+1.2%

Cash flow

See full
Operating cash flow$32.9M-26.5%
CapEx$1.2M+666%
Free cash flow$31.6M-29.0%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$919.86M-48.1%
Enterprise value$1.2B-35.7%
P/E30.2×-77.9×
P/S1.2×-1.1×

Profitability

See full
Gross margin92.8%-1.1pp
Operating margin11%+2.7pp
Net margin3.8%+1.8pp
FCF margin20.6%-2.4pp

Returns & leverage

See full
Return on equity4.5%+2.3pp
Debt / equity0.9×+0.1×
Current ratio2.6×-2.7×

Segments

By product

See full
Prescription transactions revenue$124.7M-14.0%
Pharma manufacturer solutions revenue$37.8M—
Subscription revenue$21.5M+4.1%
Other revenue$4.2M-13.8%

Versus estimates

Revenue

Q1 2026$194.0MBeat by $8.6M
Q4 2025$194.8MBeat by $1.5M
Q3 2025$196.0MBeat by $2.8MQ2 2025$203.1MMiss by $2.2MQ1 2025$203.0MBeat by $767.5KQ4 2024$198.6MMiss by $1.1M

Diluted EPS

Q1 2026$0.07In line
Q4 2025$0.09In line
Q3 2025$0.08Miss by $0.01Q2 2025$0.09Miss by $0.01Q1 2025$0.09In lineQ4 2024$0.09Miss by $0.01

Ask the moment GoodRx Holdings, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did GoodRx Holdings, Inc. report Q4 2025 earnings?
GoodRx Holdings, Inc. (GDRX) reported Q4 2025 earnings on February 25, 2026 after market close.
What were GoodRx Holdings, Inc.'s Q4 2025 revenue and EPS?
GoodRx Holdings, Inc. reported revenue of $194.8M and eps of $0.09 for Q4 2025.
Did GoodRx Holdings, Inc. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $193.3M by $1.5M. EPS beat the consensus estimate of $0.09 by $0.00.
How did GoodRx Holdings, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 1.9% from $198.6M a year earlier and eps grew 0.0% from $0.09.
Where can I find GoodRx Holdings, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001809519-26-000028) and the 10-K periodic report (0001809519-26-000031) directly on SEC EDGAR. The filing index links above go to sec.gov.